Irvine-based Trestle Holdings Inc., a maker of microscopes and other medical diagnostic devices, said Friday that its shareholders approved the sale of its assets to Clarient Inc., an Aliso Viejo-based company that does cancer and other diagnostic testing.
Trestle didn’t disclose terms of the deal.
In a June news release, Clarient said it would pay approximately $3 million in cash for Trestle’s assets.
Clarient said those assets included Trestle’s current product line and inventory, manufacturing, high-speed scanning technology and patents.
The deal allow Clarient “to cover virtually all the pathology samples needing anatomical laboratory analysis.”
